Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s12943-022-01655-0.

Title:
TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma | Molecular Cancer
Description:
Background Chimeric antigen receptor (CAR) T-cell therapy using brexucabtagene autoleucel (BA) induces remission in many patients with mantle cell lymphoma (MCL), and BA is the only CAR T-cell therapy approved by the FDA for MCL. However, development of relapses to BA is recognized with poor patient outcomes. Multiple CAR T-cell therapies have been approved for other lymphomas and the resistance mechanisms have been investigated. However, the mechanisms underlying BA relapse in MCL have not been investigated and whether any previously reported resistance mechanisms apply to BA-relapsed patients with MCL is unknown. Methods To interrogate BA resistance mechanisms in MCL, we performed single-cell RNA sequencing on 39 longitudinally collected samples from 15 BA-treated patients, and multiplex cytokine profiling on 80 serial samples from 20 patients. Results We demonstrate that after BA relapse, the proportion of T cells, especially cytotoxic T cells (CTLs), decreased among non-tumor cells, while the proportion of myeloid cells correspondingly increased. TIGIT, LAG3, and CD96 were the predominant checkpoint molecules expressed on exhausted T cells and CTLs; only TIGIT was significantly increased after relapse. CTLs expanded during remission, and then contracted during relapse with upregulated TIGIT expression. Tumor cells also acquired TIGIT expression after relapse, leading to the enhanced interaction of tumor cell TIGIT with monocyte CD155/PVR. In myeloid cells, post-relapse HLA-II expression was reduced relative to pretreatment and during remission. Myeloid-derived suppressor cells (MDSCs) were enriched after relapse with elevated expression of activation markers, including CLU (clusterin) and VCAN (versican). Extracellular chemokines (CCL4, CXCL9, CXCL13), soluble checkpoint inhibitors (sPD-L1, sTIM3, s4-1BB), and soluble receptors (sIL-2R, sTNFRII) were decreased during remission but elevated after relapse. Conclusions Our data demonstrate that multiple tumor-intrinsic and -extrinsic factors are associated with T-cell suppression and BA relapse. Among these, TIGIT appears to be the central player given its elevated expression after BA relapse in not only CTLs but also MCL cells. The acquisition of TIGIT expression on tumor cells is MCL-specific and has not been reported in other CAR T-treated diseases. Together, our data suggest that co-targeting TIGIT may prevent CAR T relapses and thus promote long-term progression-free survival in MCL patients.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Education
  • Telecommunications

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

cells, relapse, fig, cell, expression, pubmed, tigit, tcell, article, mcl, patients, tumor, google, scholar, car, central, supplementary, cancer, myeloid, patient, cytotoxic, ctls, cas, data, remission, lymphoma, therapy, receptor, immune, resistance, samples, increased, soluble, silr, hla, checkpoint, levels, wang, showing, panel, molecules, expressed, study, analysis, mechanisms, collected, significantly, elevated, genes, singlecell,

Topics {✒️}

single-cell t-cell receptor v-set immunoregulatory receptor scrna-seq/tcr library preparation large b-cell lymphoma phorbol 12-myristate 13-acetate/ionomycin inhibiting t-cell expansion article download pdf refractory mantle-cell lymphoma post-relapse hla-ii expression serine/threonine protein kinase car t-cell failure myeloid-derived suppressor cells car t-treated diseases perform single-cell separation sequential single-cell transcriptional mdsc-mediated immune suppression car-t-cell therapy car t-cell therapy car t-cell activity t-cell clone sizes trans-differentiation methylation profile cell-mediated cyeloid activation car t-cell therapies endogenous t-cell suppression car t-cell therapeutics car t-cell resistance building single-cell trajectory car t-cell exhaustion cytotoxic/exhaustion/naïve scoring algorithm regulating t-cell function cd8+ t-cell subpopulations andrew futreal & linghua wang car t-cell relapse exhausted t-cell clones myeloid-derived suppressive cells enhance cancer immunotherapy-focus serum-derived exosomes isolated therapy-induced pim1 activation immune cell populations checkpoint molecules spd-l1 tcr-independent stimulator targeting pim1-mediated metabolism cell infusion products anti-tumor cytotoxic killing human leukocyte antigens t-cell suppression mantle cell lymphoma single cells color-coded showed transcriptomic reprogramming 2d-density plots showing

Schema {🗺️}

WebPage:
      mainEntity:
         headline:TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma
         description:Chimeric antigen receptor (CAR) T-cell therapy using brexucabtagene autoleucel (BA) induces remission in many patients with mantle cell lymphoma (MCL), and BA is the only CAR T-cell therapy approved by the FDA for MCL. However, development of relapses to BA is recognized with poor patient outcomes. Multiple CAR T-cell therapies have been approved for other lymphomas and the resistance mechanisms have been investigated. However, the mechanisms underlying BA relapse in MCL have not been investigated and whether any previously reported resistance mechanisms apply to BA-relapsed patients with MCL is unknown. To interrogate BA resistance mechanisms in MCL, we performed single-cell RNA sequencing on 39 longitudinally collected samples from 15 BA-treated patients, and multiplex cytokine profiling on 80 serial samples from 20 patients. We demonstrate that after BA relapse, the proportion of T cells, especially cytotoxic T cells (CTLs), decreased among non-tumor cells, while the proportion of myeloid cells correspondingly increased. TIGIT, LAG3, and CD96 were the predominant checkpoint molecules expressed on exhausted T cells and CTLs; only TIGIT was significantly increased after relapse. CTLs expanded during remission, and then contracted during relapse with upregulated TIGIT expression. Tumor cells also acquired TIGIT expression after relapse, leading to the enhanced interaction of tumor cell TIGIT with monocyte CD155/PVR. In myeloid cells, post-relapse HLA-II expression was reduced relative to pretreatment and during remission. Myeloid-derived suppressor cells (MDSCs) were enriched after relapse with elevated expression of activation markers, including CLU (clusterin) and VCAN (versican). Extracellular chemokines (CCL4, CXCL9, CXCL13), soluble checkpoint inhibitors (sPD-L1, sTIM3, s4-1BB), and soluble receptors (sIL-2R, sTNFRII) were decreased during remission but elevated after relapse. Our data demonstrate that multiple tumor-intrinsic and -extrinsic factors are associated with T-cell suppression and BA relapse. Among these, TIGIT appears to be the central player given its elevated expression after BA relapse in not only CTLs but also MCL cells. The acquisition of TIGIT expression on tumor cells is MCL-specific and has not been reported in other CAR T-treated diseases. Together, our data suggest that co-targeting TIGIT may prevent CAR T relapses and thus promote long-term progression-free survival in MCL patients.
         datePublished:2022-09-26T00:00:00Z
         dateModified:2022-09-26T00:00:00Z
         pageStart:1
         pageEnd:16
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12943-022-01655-0
         keywords:
            Mantle cell lymphoma
            CAR T-cell therapy
            Relapse
            T cell suppression
            Myeloid-derived suppressor cells
            Immune checkpoint
            TIGIT
            Cytokines
            Chemokines
            Soluble receptors
            Cancer Research
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig6_HTML.png
         isPartOf:
            name:Molecular Cancer
            issn:
               1476-4598
            volumeNumber:21
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Vivian Changying Jiang
               affiliation:
                     name:the University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Dapeng Hao
               affiliation:
                     name:the University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Preetesh Jain
               affiliation:
                     name:the University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yijing Li
               affiliation:
                     name:the University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qingsong Cai
               affiliation:
                     name:the University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yixin Yao
               affiliation:
                     name:the University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lei Nie
               affiliation:
                     name:the University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yang Liu
               affiliation:
                     name:the University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jingling Jin
               affiliation:
                     name:the University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wei Wang
               affiliation:
                     name:the University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Heng-Huan Lee
               affiliation:
                     name:the University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yuxuan Che
               affiliation:
                     name:the University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Enyu Dai
               affiliation:
                     name:the University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Guangchun Han
               affiliation:
                     name:the University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ruiping Wang
               affiliation:
                     name:the University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kunal Rai
               affiliation:
                     name:the University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Andrew Futreal
               affiliation:
                     name:the University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Christopher Flowers
               affiliation:
                     name:the University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Linghua Wang
               affiliation:
                     name:the University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
                     name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS)
                     address:
                        name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Michael Wang
               affiliation:
                     name:the University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
                     name:the University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma
      description:Chimeric antigen receptor (CAR) T-cell therapy using brexucabtagene autoleucel (BA) induces remission in many patients with mantle cell lymphoma (MCL), and BA is the only CAR T-cell therapy approved by the FDA for MCL. However, development of relapses to BA is recognized with poor patient outcomes. Multiple CAR T-cell therapies have been approved for other lymphomas and the resistance mechanisms have been investigated. However, the mechanisms underlying BA relapse in MCL have not been investigated and whether any previously reported resistance mechanisms apply to BA-relapsed patients with MCL is unknown. To interrogate BA resistance mechanisms in MCL, we performed single-cell RNA sequencing on 39 longitudinally collected samples from 15 BA-treated patients, and multiplex cytokine profiling on 80 serial samples from 20 patients. We demonstrate that after BA relapse, the proportion of T cells, especially cytotoxic T cells (CTLs), decreased among non-tumor cells, while the proportion of myeloid cells correspondingly increased. TIGIT, LAG3, and CD96 were the predominant checkpoint molecules expressed on exhausted T cells and CTLs; only TIGIT was significantly increased after relapse. CTLs expanded during remission, and then contracted during relapse with upregulated TIGIT expression. Tumor cells also acquired TIGIT expression after relapse, leading to the enhanced interaction of tumor cell TIGIT with monocyte CD155/PVR. In myeloid cells, post-relapse HLA-II expression was reduced relative to pretreatment and during remission. Myeloid-derived suppressor cells (MDSCs) were enriched after relapse with elevated expression of activation markers, including CLU (clusterin) and VCAN (versican). Extracellular chemokines (CCL4, CXCL9, CXCL13), soluble checkpoint inhibitors (sPD-L1, sTIM3, s4-1BB), and soluble receptors (sIL-2R, sTNFRII) were decreased during remission but elevated after relapse. Our data demonstrate that multiple tumor-intrinsic and -extrinsic factors are associated with T-cell suppression and BA relapse. Among these, TIGIT appears to be the central player given its elevated expression after BA relapse in not only CTLs but also MCL cells. The acquisition of TIGIT expression on tumor cells is MCL-specific and has not been reported in other CAR T-treated diseases. Together, our data suggest that co-targeting TIGIT may prevent CAR T relapses and thus promote long-term progression-free survival in MCL patients.
      datePublished:2022-09-26T00:00:00Z
      dateModified:2022-09-26T00:00:00Z
      pageStart:1
      pageEnd:16
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12943-022-01655-0
      keywords:
         Mantle cell lymphoma
         CAR T-cell therapy
         Relapse
         T cell suppression
         Myeloid-derived suppressor cells
         Immune checkpoint
         TIGIT
         Cytokines
         Chemokines
         Soluble receptors
         Cancer Research
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig6_HTML.png
      isPartOf:
         name:Molecular Cancer
         issn:
            1476-4598
         volumeNumber:21
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Vivian Changying Jiang
            affiliation:
                  name:the University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Dapeng Hao
            affiliation:
                  name:the University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Preetesh Jain
            affiliation:
                  name:the University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yijing Li
            affiliation:
                  name:the University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qingsong Cai
            affiliation:
                  name:the University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yixin Yao
            affiliation:
                  name:the University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lei Nie
            affiliation:
                  name:the University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yang Liu
            affiliation:
                  name:the University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jingling Jin
            affiliation:
                  name:the University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wei Wang
            affiliation:
                  name:the University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Heng-Huan Lee
            affiliation:
                  name:the University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yuxuan Che
            affiliation:
                  name:the University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Enyu Dai
            affiliation:
                  name:the University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Guangchun Han
            affiliation:
                  name:the University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ruiping Wang
            affiliation:
                  name:the University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kunal Rai
            affiliation:
                  name:the University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Andrew Futreal
            affiliation:
                  name:the University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Christopher Flowers
            affiliation:
                  name:the University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Linghua Wang
            affiliation:
                  name:the University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
                  name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS)
                  address:
                     name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Michael Wang
            affiliation:
                  name:the University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
                  name:the University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Molecular Cancer
      issn:
         1476-4598
      volumeNumber:21
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:the University of Texas MD Anderson Cancer Center
      address:
         name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:the University of Texas MD Anderson Cancer Center
      address:
         name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:the University of Texas MD Anderson Cancer Center
      address:
         name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:the University of Texas MD Anderson Cancer Center
      address:
         name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:the University of Texas MD Anderson Cancer Center
      address:
         name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:the University of Texas MD Anderson Cancer Center
      address:
         name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:the University of Texas MD Anderson Cancer Center
      address:
         name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:the University of Texas MD Anderson Cancer Center
      address:
         name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:the University of Texas MD Anderson Cancer Center
      address:
         name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:the University of Texas MD Anderson Cancer Center
      address:
         name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:the University of Texas MD Anderson Cancer Center
      address:
         name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:the University of Texas MD Anderson Cancer Center
      address:
         name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:the University of Texas MD Anderson Cancer Center
      address:
         name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:the University of Texas MD Anderson Cancer Center
      address:
         name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:the University of Texas MD Anderson Cancer Center
      address:
         name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:the University of Texas MD Anderson Cancer Center
      address:
         name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:the University of Texas MD Anderson Cancer Center
      address:
         name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:the University of Texas MD Anderson Cancer Center
      address:
         name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:the University of Texas MD Anderson Cancer Center
      address:
         name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS)
      address:
         name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, USA
         type:PostalAddress
      name:the University of Texas MD Anderson Cancer Center
      address:
         name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:the University of Texas MD Anderson Cancer Center
      address:
         name:Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Vivian Changying Jiang
      affiliation:
            name:the University of Texas MD Anderson Cancer Center
            address:
               name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Dapeng Hao
      affiliation:
            name:the University of Texas MD Anderson Cancer Center
            address:
               name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Preetesh Jain
      affiliation:
            name:the University of Texas MD Anderson Cancer Center
            address:
               name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Yijing Li
      affiliation:
            name:the University of Texas MD Anderson Cancer Center
            address:
               name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Qingsong Cai
      affiliation:
            name:the University of Texas MD Anderson Cancer Center
            address:
               name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Yixin Yao
      affiliation:
            name:the University of Texas MD Anderson Cancer Center
            address:
               name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Lei Nie
      affiliation:
            name:the University of Texas MD Anderson Cancer Center
            address:
               name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Yang Liu
      affiliation:
            name:the University of Texas MD Anderson Cancer Center
            address:
               name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Jingling Jin
      affiliation:
            name:the University of Texas MD Anderson Cancer Center
            address:
               name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Wei Wang
      affiliation:
            name:the University of Texas MD Anderson Cancer Center
            address:
               name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Heng-Huan Lee
      affiliation:
            name:the University of Texas MD Anderson Cancer Center
            address:
               name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Yuxuan Che
      affiliation:
            name:the University of Texas MD Anderson Cancer Center
            address:
               name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Enyu Dai
      affiliation:
            name:the University of Texas MD Anderson Cancer Center
            address:
               name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Guangchun Han
      affiliation:
            name:the University of Texas MD Anderson Cancer Center
            address:
               name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Ruiping Wang
      affiliation:
            name:the University of Texas MD Anderson Cancer Center
            address:
               name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Kunal Rai
      affiliation:
            name:the University of Texas MD Anderson Cancer Center
            address:
               name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Andrew Futreal
      affiliation:
            name:the University of Texas MD Anderson Cancer Center
            address:
               name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Christopher Flowers
      affiliation:
            name:the University of Texas MD Anderson Cancer Center
            address:
               name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Linghua Wang
      affiliation:
            name:the University of Texas MD Anderson Cancer Center
            address:
               name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
            name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS)
            address:
               name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Michael Wang
      affiliation:
            name:the University of Texas MD Anderson Cancer Center
            address:
               name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
            name:the University of Texas MD Anderson Cancer Center
            address:
               name:Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
      name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, USA
      name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas MD Anderson Cancer Center, Houston, USA

External Links {🔗}(231)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.87s.